Seelos Therapeutics(SEELQ)
$0.000.00 (0.00%)
SEELQ
Seelos Therapeutics Statistics
$0.00
At close:0.00 (0.00%)
Want to see SEELQ full AI Analyst Report?
Seelos Therapeutics (SEELQ) Stock Statistics & Valuation Metrics
1,198 Followers
Total Valuation
Seelos Therapeutics has a market cap or net worth of $1.00. The enterprise value is $11.36T.
- Market Cap
- $1.00
- Enterprise Value
- $11.36T
Share Statistics
Seelos Therapeutics has 1,362,880 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 1,362,880
- Owned by Insiders
- ―
- Owned by Institutions
- 2.36%
Financial Efficiency
Seelos Therapeutics’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
- Return on Equity (ROE)
- ―
- Return on Assets (ROA)
- ―
- Return on Invested Capital (ROIC)
- ―
- Return on Capital Employed (ROCE)
- ―
- Revenue Per Employee
- ―
- Profits Per Employee
- -464.56K
- Employee Count
- 16
- Asset Turnover
- ―
- Inventory Turnover
- ―
Income Statement
In the last 12 months, Seelos Therapeutics had revenue of ― and earned -7.43M in profits. Earnings per share was ―.
- Revenue
- ―
- Gross Profit
- 1.87M
- Operating Income
- -13.66M
- Pretax Income
- ―
- Net Income
- -7.43M
- EBITDA
- -6.57M
- Earnings Per Share (EPS)
- ―
Stock Price Statistics
- Beta
- -25.17
- 52-Week Price Change
- 0.00%
- 50-Day Moving Average
- 0.18
- 200-Day Moving Average
- 0.18
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Important Dates
Seelos Therapeutics upcoming earnings date is ―, TBA (Not Confirmed).
- Last Earnings Date
- Apr 25, 2025
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Balance Sheet
Seelos Therapeutics has ― in cash and marketable securities with $147.00K in debt, giving a net cash position of ― billion.
- Cash & Marketable Securities
- ―
- Total Debt
- $147.00K
- Net Cash
- ―
- Net Cash Per Share
- ―
- Tangible Book Value Per Share
- ―
Scores
- Smart Score
- ―
- AI Score
- 30

